Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non–Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features

IMPORTANCE: Tumor size larger than 4 cm is accepted as an indication for adjuvant chemotherapy in patients with node-negative non–small cell lung cancer (NSCLC). Treatment guidelines suggest that high-risk features are also associated with the efficacy of adjuvant chemotherapy among patients with ea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Oncol
Autors principals: Pathak, Ranjan, Goldberg, Sarah B., Canavan, Maureen, Herrin, Jeph, Hoag, Jessica R., Salazar, Michelle C., Papageorge, Marianna, Ermer, Theresa, Boffa, Daniel J.
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2020
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7499246/
https://ncbi.nlm.nih.gov/pubmed/32940636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2020.4232
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars